Who owns LONGBOARD PHARMACEUTICALS IN?

Tip: Access positions for across all investors

Analyze quarterly positions in Longboard Pharmaceuticals In with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Longboard Pharmaceuticals In stock

Who bought or sold LONGBOARD PHARMACEUTICALS IN this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Cormorant Asset Management 2.4M $14M 0% Dec 2023
 View chart
FMR 2.1M $12M -18% Sep 2023
 View chart
T. Rowe Price Associates 1.6M $9.8M -8% Dec 2023
 View chart
Farallon Capital Management 1.6M $8.7M 56% Sep 2023
 View chart
Polar Capital Holdings 1.0M $5.6M 100% Sep 2023
 View chart
Ikarian Capital 980k $5.9M 91% Dec 2023
 View chart
Point72 Asset Management 825k $5.0M 0% Dec 2023
 View chart
Vanguard Group 786k $4.7M 1% Dec 2023
 View chart
BlackRock 786k $4.4M 6% Sep 2023
 View chart
Integral Health Asset Management 760k $4.2M 27% Sep 2023
 View chart
Jpmorgan Chase & Co 535k $3.2M 0% Dec 2023
 View chart
Jennison Associates 481k $2.9M 100% Dec 2023
 View chart
Parkman Healthcare Partners 356k $2.0M 4% Sep 2023
 View chart
Geode Capital Management 332k $1.8M 1% Sep 2023
 View chart
Prosight Management 321k $1.8M -56% Sep 2023
 View chart
State Street Corporation 294k $1.6M 0% Sep 2023
 View chart
UBS O'Connor 262k $1.5M 0% Sep 2023
 View chart
CIBC Global Asset Management 145k $804k 0% Sep 2023
 View chart
Northern Trust 137k $761k 2% Sep 2023
 View chart
Boothbay Fund Management 113k $626k 10% Sep 2023
 View chart
TD Asset Management 94k $567k -23% Dec 2023
 View chart
Schonfeld Strategic Advisors 92k $557k 10% Dec 2023
 View chart
Woodline Partners 81k $452k -28% Sep 2023
 View chart
Bridgeway Capital Management 50k $278k 0% Sep 2023
 View chart
Bank of New York Mellon 46k $276k 0% Dec 2023
 View chart
Charles Schwab Investment Management 43k $259k 0% Dec 2023
 View chart
Manufacturers Life Insurance Company 42k $236k 9% Sep 2023
 View chart
Walleye Trading Advisors 39k $237k 100% Dec 2023
 View chart
Dimensional Fund Advisors 33k $198k 164% Dec 2023
 View chart
Jacobs Levy Equity Management 24k $144k 100% Dec 2023
 View chart
Laurion Capital Management 22k $132k -17% Dec 2023
 View chart
Nuveen Asset Management 22k $121k 0% Sep 2023
 View chart
Barclays 21k $129k 669% Dec 2023
 View chart
Bank of America Corporation 19k $112k 44% Dec 2023
 View chart
Rhumbline Advisers 16k $98k 0% Dec 2023
 View chart
UBS Group 15k $92k 84% Dec 2023
 View chart
Goldman Sachs Group 14k $83k 24% Dec 2023
 View chart
New York State Common Retirement Fund 12k $73k 0% Dec 2023
 View chart
American International 7.7k $47k 0% Dec 2023
 View chart
Morgan Stanley 7.1k $39k -35% Sep 2023
 View chart
Bourgeon Capital Management 7.0k $42k 0% Dec 2023
 View chart
Royal Bank of Canada 5.2k $31k 94% Dec 2023
 View chart
Wells Fargo & Company 4.5k $27k 26% Dec 2023
 View chart
Tower Research Capital 4.3k $24k 724% Sep 2023
 View chart
California State Teachers Retirement System 3.4k $19k -34% Sep 2023
 View chart
OTR - Nominee Name for The State Teachers Retirement Board of Ohio 3.2k $19k 0% Dec 2023
 View chart
Dorsey Wright & Associates 3.0k $17k -3% Sep 2023
 View chart
Citigroup 2.3k $14k 32071% Dec 2023
 View chart
Legal & General Group 1.7k $10k 0% Dec 2023
 View chart
Amalgamated Bank 1.7k $10k -9% Dec 2023
 View chart
Summit Investment Advisors 1.3k $7.8k 0% Dec 2023
 View chart
ADAR1 Capital Management 800.00 $4.8k 100% Dec 2023
 View chart

Who sold out of Longboard Pharmaceuticals In?

Fund or Company Name Date Sold Shares Held Valued At
Moore Capital Management Sep 2023 46k $254k
Millennium Management Sep 2023 17k $95k
Renaissance Technologies Jun 2023 16k $115k
Allspring Global Investments Holdings Sep 2023 1.4k $7.6k